cjc 1295 with retatrutide and ipamorelin CJC-1295 no DAC + Ipamorelin Blend 10mg CJC-1295 (DAC) — 5mg |
Description
Retatrutide is a groundbreaking new treatment that has the potential to revolutionize the way we approach various medical conditions
At the same time, the competitive paradigm is shifting beyond injectables
Hurry up and order now
Retatrutide (research code LY-3437943) is a synthetic 39-amino-acid peptide developed by Eli Lilly as a novel triple agonist of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIP-R), and glucagon receptor (GCG-R)
